Although the literature on ILCs in COPD is still minimal (425, 426), the role of ILC3s in COPD warrants investigation since IL-17, its principal cytokine, has already been described as a known driver of neutrophilic inflammation, and individuals with COPD have increased levels of IL-17 (426, 427). Here, IL17A is linked to chronic obstructive pulmonary disease.